MHRA approves Venclyxto for newly diagnosed AML
11th June 2021 Uncategorised 0The approval is based on results from the Phase III VIALE-A study as well as the Phase Ib M14-358 clinical trial More: MHRA approves Venclyxto for newly diagnosed AML Source: News
read more